2825 Airview Boulevard
224 articles with Stryker
Stryker announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020.
Stryker, one of the world’s leading medical technology companies, announced it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year.
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.
Purchase Price of $30.75 Per Share in Cash; Total Enterprise Value of Approximately $5.4 Billion and Total Equity Value of Approximately $4.7 Billion
Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics.
Stryker announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its SAHARA Lateral 3D Expandable Interbody System featuring Lamellar 3D Titanium Technology, which will be on display at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum this week in Las Vegas, NV.
Stryker (NYSE:SYK) reported operating results for the third quarter of 2019
According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.
BioSpace, the leader in life sciences news and careers, today announced that Genentech, Pfizer, Merck, Amgen and Novartis landed in the top five spots of their latest Ideal Employer report.
All amounts in this press release are in Canadian dollars unless otherwise specified.
Chronic sinusitis and bacteria-caused sinus infections are the most prevalent health issues witnessed in various countries.
Konica Minolta Healthcare, Novo Nordisk, Philips and Stryker join Emory Healthcare Innovation Hub with Sharecare to improve health care for all
More than 10 projects underway aim to impact personalized medicine, telehealth, imaging and genetics
Stryker receives FDA premarket approval for the Neuroform Atlas® Stent System to treat brain aneurysms
Stryker announced the Premarket Approval of the Neuroform Atlas Stent System by the U.S. Food and Drug Administration.
At AANA 2019, Stryker hosts a lunch-and-learn presentation featuring a new surgical planning and execution platform designed to enhance efficiency and patient experience for hip arthroscopy
Shane Nho, M.D., M.S., Midwest Orthopaedics at Rush, to present on HipCheck and HipMap, innovative tools designed to deliver procedural efficiency, facilitate patient education and improve patient-specific results
Stryker Launches LIFEPAK® CR2 Defibrillator with LIFELINKcentral™ AED Program Manager in the United States
New LIFEPAK AED Response System Offers Connectivity, Intuitive Design and Unique Technology to Analyze Heart Rhythm during CPR [11-April-2019] REDMOND, Wash. , USA, April 11, 2019 /PRNewswire/ -- Stryker has launched the company's newest defibrillation solution, the LIFEPAK ® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States . The c
OrthoSpace was founded in 2009 and the Company's InSpace product provides a highly differentiated technology for the treatment of massive irreparable rotator cuff tears.
T2 Alpha nails and ADAPT software seamlessly aid surgeons as a complete nailing portfolio
The ReUnion S stem is designed to be the ideal length humeral stem, optimizing bone preservation, alignment and stability as part of the ReUnion Shoulder Arthroplasty System
Stryker Announces Clinical Evidence Demonstrating Improved Early Functional Recovery with Mako Total Knee
Two distinct clinical studies demonstrate Mako Total Knee associated with less pain, less need for opiate analgesics, less need for in-patient physical therapy, reduction in length of hospital stay, improved knee flexion and soft tissue protection in comparison to manual techniques
Stryker introduces new visualization platform designed to enhance orthopaedic surgical efficiency and the patient experience
Advanced tools designed to deliver procedural efficiency and improved patient-specific results